Atea Pharmaceuticals, Inc. (AVIR) Ownership

$3.35

north_east $0.02 (0.6%)
Day's range
$3.33
Day's range
$3.4

Atea Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK FUNDING, INC. /DE 11/13/2024 8.99 M $30.12 M   100.00% 10.65%
BML CAPITAL MANAGEMENT, LLC 11/05/2024 6.65 M $22.28 M   4.30% 7.88%
FMR LLC 11/13/2024 6.62 M $22.17 M   2.83% 7.84%
ECOR1 CAPITAL, LLC 11/14/2024 5.44 M $18.23 M   0.00% 6.45%
VANGUARD GROUP INC 11/13/2024 4.85 M $16.25 M   2.68% 5.75%
TANG CAPITAL MANAGEMENT LLC 11/14/2024 4.61 M $15.43 M   2.91% 5.46%
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC 11/14/2024 2.49 M $8.33 M   0.00% 2.94%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2024 1.92 M $6.45 M   -4.23% 2.28%
STATE STREET CORP 11/14/2024 1.73 M $5.81 M   0.67% 2.05%
ALMITAS CAPITAL LLC 11/14/2024 1.38 M $4.64 M   7.31% 1.64%
RENAISSANCE TECHNOLOGIES LLC 11/13/2024 1.21 M $4.04 M   5.75% 1.43%
ACADIAN ASSET MANAGEMENT LLC 11/12/2024 932,925 $3.12 M   -0.17% 1.11%
DIMENSIONAL FUND ADVISORS LP 11/07/2024 793,626 $2.66 M   33.53% 0.94%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/12/2024 650,157 $2.18 M   8.47% 0.77%
CITADEL ADVISORS LLC 11/14/2024 595,249 $1.99 M   13.25% 0.71%
TWO SIGMA ADVISERS, LP 11/14/2024 582,400 $1.95 M   -4.87% 0.69%
JACOBS LEVY EQUITY MANAGEMENT, INC 11/14/2024 509,471 $1.71 M   -9.81% 0.60%
MORGAN STANLEY 11/14/2024 488,899 $1.64 M   33.02% 0.58%
NEWTYN MANAGEMENT, LLC 11/14/2024 380,000 $1.27 M   0.00% 0.45%
BANQUE PICTET & CIE SA 10/21/2024 345,077 $1.16 M   0.00% 0.41%
TWO SIGMA INVESTMENTS, LP 11/14/2024 341,761 $1.14 M   -8.88% 0.40%
ACUITAS INVESTMENTS, LLC 11/07/2024 323,542 $1.08 M   24.78% 0.38%
GOLDMAN SACHS GROUP INC 11/14/2024 300,928 $1.01 M   35.96% 0.36%
NUVEEN ASSET MANAGEMENT, LLC 11/14/2024 291,091 $975,154   0.00% 0.34%
CM MANAGEMENT, LLC 11/12/2024 270,000 $904,500   0.00% 0.32%
WELLINGTON MANAGEMENT GROUP LLP 11/14/2024 221,562 $742,233   -13.17% 0.26%
BANK OF NEW YORK MELLON CORP 11/12/2024 212,690 $712,512   -20.10% 0.25%
INVESCO LTD. 11/12/2024 194,529 $651,672   -0.26% 0.23%
D. E. SHAW & CO., INC. 11/14/2024 193,578 $648,486   30.87% 0.23%
BARCLAYS PLC 11/19/2024 177,077 $593,000   74.54% 0.21%
AUOUR INVESTMENTS LLC 10/30/2024 177,000 $600,030   0.00% 0.21%
RBF CAPITAL, LLC 11/14/2024 148,451 $496,714   0.00% 0.18%
AMERICAN CENTURY COMPANIES INC 11/12/2024 143,196 $479,707   14.40% 0.17%
RHUMBLINE ADVISERS 11/12/2024 133,114 $445,919   -3.26% 0.16%
ALLIANCEBERNSTEIN L.P. 11/14/2024 119,220 $399,387   0.00% 0.14%
STATE OF WISCONSIN INVESTMENT BOARD 11/14/2024 109,200 $365,820   -23.80% 0.13%
STRS OHIO 11/01/2024 105,500 $353,425   0.00% 0.13%
WOODLINE PARTNERS LP 11/14/2024 103,358 $346,249   100.00% 0.12%
AMERIPRISE FINANCIAL INC 11/14/2024 98,069 $328,531   -3.66% 0.12%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2024 97,300 $325,955   -45.79% 0.12%
JPMORGAN CHASE & CO 12/26/2024 95,244 $319,067   106.08% 0.11%
JANE STREET GROUP, LLC 11/15/2024 92,285 $309,154   -2.79% 0.11%
UBS GROUP AG 11/14/2024 78,391 $262,610   9.52% 0.09%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2024 70,001 $235,000   5.01% 0.08%
MACQUARIE GROUP LTD 11/14/2024 70,000 $235,000   0.00% 0.08%
BERKSHIRE ASSET MANAGEMENT LLC/PA 11/14/2024 65,000 $215,150   0.00% 0.08%
ALPS ADVISORS INC 11/12/2024 64,692 $216,718   -1.50% 0.08%
BANK OF AMERICA CORP /DE/ 11/14/2024 59,539 $199,455   -14.30% 0.07%
VERITION FUND MANAGEMENT LLC 11/14/2024 56,909 $190,645   -13.74% 0.07%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2024 53,168 $178,113   -21.29% 0.06%

Atea Pharmaceuticals, Inc.institutional Ownership - FAQ's

Who are the largest shareholders of AVIR shares?

During the previous two years, 122 institutional investors and hedge funds held shares of Atea Pharmaceuticals, Inc.. The most heavily invested institutionals were:

BlackRock Funding, Inc. /DE: 8.99 M

BML Capital Management, LLC: 6.65 M

FMR LLC: 6.62 M

EcoR1 Capital, LLC: 5.44 M

VANGUARD GROUP INC: 4.85 M

TANG CAPITAL MANAGEMENT LLC: 4.61 M

What percentage of Atea Pharmaceuticals, Inc. stock is owned by institutional investors?

68.59% of Atea Pharmaceuticals, Inc. stock is owned by institutional investors.

How much institutional buying is happening at AVIR ?

Institutional investors have bought a total of 66.97 M shares in the last 24 months. This purchase volume represents approximately $224.36 M in transactions.